Cigna Group $CI Shares Sold by Munich Reinsurance Co Stock Corp in Munich

Key Points

• Munich Reinsurance cut its stake in Cigna by 36.4% in Q4, selling 8,254 shares and leaving it with 14,392 shares valued at about $3.98 million, while institutional investors still own roughly 86.99% of the stock.
• Cigna beat Q4 expectations with $8.08 EPS (vs. $7.88 est.) and $72.5 billion in revenue, issued FY2026 EPS guidance of 30.25, and analysts collectively forecast about 30.32 EPS for the year.
• Two insiders sold shares recently (Nicole S. Jones 2,307 shares; Everett Neville 1,719 shares), the company declared a quarterly dividend of $1.56 (annualized $6.24, yield 2.3%), and analyst coverage remains mostly positive with an average price target near $332.47.

Munich Reinsurance Co Stock Corp in Munich lessened its stake in Cigna Group (NYSE:CI - Free Report) by 36.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,392 shares of the health services provider's stock after selling 8,254 shares during the quarter. Munich Reinsurance Co Stock Corp in Munich's holdings in Cigna Group were worth $3,979,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. HM Payson & Co. grew its position in Cigna Group by 0.9% in the third quarter. HM Payson & Co. now owns 3,785 shares of the health services provider's stock worth $1,091,000 after acquiring an additional 35 shares during the period. OLD National Bancorp IN grew its position in Cigna Group by 3.7% in the fourth quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider's stock worth $284,000 after acquiring an additional 37 shares during the period. Leavell Investment Management Inc. grew its position in Cigna Group by 3.8% in the third quarter. Leavell Investment Management Inc. now owns 1,103 shares of the health services provider's stock worth $318,000 after acquiring an additional 40 shares during the period. Physician Wealth Advisors Inc. grew its position in Cigna Group by 1.5% in the third quarter. Physician Wealth Advisors Inc. now owns 2,712 shares of the health services provider's stock worth $782,000 after acquiring an additional 41 shares during the period. Finally, Cookson Peirce & Co. Inc. grew its position in Cigna Group by 0.8% in the third quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider's stock worth $1,428,000 after acquiring an additional 41 shares during the period. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Everett Neville sold 1,719 shares of the firm's stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the sale, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is currently owned by company insiders.

Cigna Group Stock Down 1.5%

Shares of NYSE CI opened at $275.44 on Friday. The stock has a market cap of $72.59 billion, a P/E ratio of 12.42, a PEG ratio of 0.97 and a beta of 0.26. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The business's fifty day simple moving average is $274.50 and its 200-day simple moving average is $277.43.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.88 by $0.20. The business had revenue of $72.50 billion for the quarter, compared to analysts' expectations of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the firm earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities analysts predict that Cigna Group will post 30.32 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group's dividend payout ratio (DPR) is presently 28.13%.

Analyst Ratings Changes

Several research analysts recently weighed in on CI shares. Wall Street Zen upgraded Cigna Group from a "hold" rating to a "buy" rating in a research report on Saturday, February 7th. Mizuho set a $325.00 price objective on Cigna Group in a research report on Friday, January 9th. Leerink Partners increased their price objective on Cigna Group from $270.00 to $297.00 and gave the stock a "market perform" rating in a research report on Friday, February 6th. Barclays lowered their price objective on Cigna Group from $305.00 to $303.00 and set an "overweight" rating for the company in a research report on Friday, February 6th. Finally, Piper Sandler decreased their price target on Cigna Group from $374.00 to $370.00 and set an "overweight" rating on the stock in a research note on Tuesday, March 3rd. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $332.47.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna joined other major plans in a public commitment to standardize electronic prior-authorization requirements for commonly reviewed services — a move that should reduce provider administrative burden, speed patient access to care, and lower long‑term costs for payers. Article Title
• Positive Sentiment: Industry press highlights progress across UnitedHealthcare, Aetna and Cigna toward standardizing prior authorization — reinforcing that this is an industry-wide trend (reduces regulatory/operational risk if successfully implemented). Article Title
• Positive Sentiment: Cigna declared a quarterly dividend ($1.56 per share; ex-dividend in June), underscoring cash return to shareholders and supporting income-focused investor demand. Dividend Announcement
• Positive Sentiment: Analysts and previews (Zacks) expect earnings growth into the next report, which could support a post‑earnings rebound if Cigna posts another beat. Article Title
• Neutral Sentiment: Cigna promoted Melissa Skottegaard to chief marketing & communications officer — a leadership move that may affect branding/execution but is unlikely to move near‑term financials. Article Title
• Neutral Sentiment: Reminders that Cigna is scheduled to report results next week (earnings date/coverage notices) keep focus on near-term catalysts rather than fundamental surprises. Article Title
• Negative Sentiment: Jefferies reaffirmed a Buy on CI but trimmed its price target slightly (reportedly from $333 to $330) after reviewing health insurance exchange exposure — the analyst tweak likely pressured sentiment and fed selling pressure. Article Title

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.